CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Tickers
- ACHV QUIT
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
Securities
- ACHV Common stock Nasdaq
- QUIT Common Shares Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-08-21 | Cormack Scott Daniel President & CEO | Grant or award · Stock Option (right to buy) | +46,137 | 46,137 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +2,393 | 2,393 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +952 | 952 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +3,699 | 3,699 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +513 | 513 | ||
| 2008-08-21 | Clendeninn Neil James Director | Grant or award · Stock Option (right to buy) | +3,046 | 3,046 | ||
| 2008-08-21 | Anderson Stephen Charles CFO & Secretary | Grant or award · Stock Option (right to buy) | +21,763 | 21,763 | ||
| 2008-03-18 | MARTINO MICHAEL A President & CEO | Grant or award · Non-qualified stock option (right to buy) | +425,000 | 425,000 | ||
| 2008-03-18 | Fuhrman Alan Senior Vice President & CFO | Grant or award · Non-qualified stock option (right to buy) | +275,000 | 275,000 | ||
| 2007-05-18 | IVY ROBERT E Director | Option exercise | +10,000 | $0.63 | $6K | 11,700 |
| 2007-05-18 | IVY ROBERT E Director | Sale | −10,000 | $5.46 | $55K | 1,700 |
| 2007-05-18 | IVY ROBERT E Director | Option exercise · Non-qualified stock option (right to buy) | −10,000 | 10,000 | ||
| 2007-05-17 | IVY ROBERT E Director | Option exercise | +10,000 | $0.63 | $6K | 11,700 |
| 2007-05-17 | IVY ROBERT E Director | Sale | −10,000 | $5.36 | $54K | 1,700 |
| 2007-05-17 | IVY ROBERT E Director | Option exercise · Non-qualified stock option (right to buy) | −10,000 | 20,000 | ||
| 2007-05-16 | IVY ROBERT E Director | Option exercise | +10,000 | $0.63 | $6K | 11,700 |
| 2007-05-16 | IVY ROBERT E Director | Sale | −10,000 | $5.40 | $54K | 1,700 |
| 2007-05-16 | IVY ROBERT E Director | Option exercise · Non-qualified stock option (right to buy) | −10,000 | 30,000 | ||
| 2007-05-10 | WINSTEAD DWIGHT Director | Grant or award · Non-qualified stock option (right to buy) | +17,000 | 17,000 | ||
| 2007-05-10 | IVY ROBERT E Director | Grant or award · Non-qualified stock option (right to buy) | +17,000 | 17,000 |
Page 43 of 46 · 905 trades